tradingkey.logo
tradingkey.logo
Search

AnaptysBio Inc

ANAB
Add to Watchlist
53.360USD
-1.680-3.05%
Close 07-31 16:00ETQuotes delayed by 15 min
1.58BMarket Cap
LossP/E TTM

ANAB Financials

See AnaptysBio Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

AnaptysBio Inc Earnings Date

Latest Release
May 12, 2026
EPS / Forecast
-1.84/-0.67
Revenue / Forecast
25.56M/28.97M
Period
FY2025 Earnings
Revenue(YoY)
234.60M
157.01%
EPS(YoY)
-0.46
91.01%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-43.62%-1.84
35.65%-0.46
147.76%0.54
21.39%-1.34
21.71%-1.28
54.97%-0.72
19.10%-1.14
-13.99%-1.71
-3.55%-1.64
-71.02%-1.59
---1.41
---1.50
---1.58
---0.93
---3.64
----
----
----
----
----
Revenue
-7.98%25.56M
151.08%108.25M
154.26%76.32M
102.93%22.26M
286.84%27.77M
378.77%43.11M
804.67%30.02M
217.08%10.97M
422.49%7.18M
32.27%9.01M
156.61%3.32M
184.54%3.46M
41.65%1.37M
573.39%6.81M
-93.81%1.29M
-95.95%1.22M
-91.38%970.00K
-98.31%1.01M
--20.89M
--30.03M
Net Profit
-34.47%-52.88M
327.75%49.61M
146.00%15.11M
17.21%-38.63M
10.49%-39.33M
48.39%-21.78M
11.95%-32.85M
-17.10%-46.66M
0.72%-43.94M
-59.81%-42.21M
-11.36%-37.31M
-22.40%-39.84M
-22.07%-44.26M
18.82%-26.41M
-402.58%-33.50M
-7488.34%-32.55M
-99.61%-36.26M
-196.71%-32.54M
71.95%-6.67M
98.01%-429.00K
Net Margin
-46.12%-206.93%
88.84%-5.64%
118.09%19.80%
59.20%-173.52%
76.86%-141.62%
89.22%-50.53%
90.27%-109.44%
63.07%-425.30%
81.00%-612.01%
-20.82%-468.75%
---1124.41%
---1151.59%
---3220.89%
---387.97%
---2940.82%
----
----
----
----
----
Gross Margin
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
Debt to assets ratio
--80.00%
--75.89%
--93.98%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Revenue
-7.98%25.56M
151.08%108.25M
154.26%76.32M
102.93%22.26M
286.84%27.77M
378.77%43.11M
804.67%30.02M
217.08%10.97M
422.49%7.18M
32.27%9.01M
156.61%3.32M
184.54%3.46M
41.65%1.37M
573.39%6.81M
-93.81%1.29M
-95.95%1.22M
-91.38%970.00K
-98.31%1.01M
--20.89M
--30.03M
Operating profit
-25.77%-34.64M
791.84%66.90M
252.50%34.70M
35.10%-26.17M
34.74%-27.54M
72.21%-9.67M
39.69%-22.76M
-0.44%-40.32M
4.95%-42.20M
-33.97%-34.80M
-27.33%-37.73M
-44.40%-40.14M
-39.85%-44.40M
16.64%-25.97M
-338.16%-29.63M
-5115.57%-27.80M
-72.92%-31.75M
-193.44%-31.16M
72.21%-6.76M
97.65%-533.00K
Net Profit
-34.47%-52.88M
327.75%49.61M
146.00%15.11M
17.21%-38.63M
10.49%-39.33M
48.39%-21.78M
11.95%-32.85M
-17.10%-46.66M
0.72%-43.94M
-59.81%-42.21M
-11.36%-37.31M
-22.40%-39.84M
-22.07%-44.26M
18.82%-26.41M
-402.58%-33.50M
-7488.34%-32.55M
-99.61%-36.26M
-196.71%-32.54M
71.95%-6.67M
98.01%-429.00K
Current assets
-12.94%316.11M
-18.90%350.25M
-26.31%330.65M
-20.54%291.91M
-2.50%363.11M
6.16%431.88M
4.83%448.68M
-16.23%367.35M
-14.81%372.42M
-9.03%406.83M
-4.98%428.00M
-3.15%438.54M
-14.69%437.15M
-19.26%447.20M
16.50%450.44M
13.75%452.81M
32.36%512.41M
39.67%553.88M
11.81%386.64M
3.52%398.06M
Total current liabilities
-5.30%41.70M
-14.98%38.63M
-13.16%38.10M
-12.11%35.53M
36.35%44.04M
21.33%45.43M
12.00%43.88M
-2.91%40.42M
-9.77%32.30M
43.71%37.44M
86.00%39.18M
109.51%41.63M
80.96%35.80M
61.84%26.05M
0.83%21.06M
-3.61%19.87M
36.66%19.78M
-18.78%16.10M
-14.65%20.89M
2.41%20.62M
Total assets
-21.89%329.68M
-24.69%364.39M
-28.44%353.10M
-21.56%335.25M
4.00%422.05M
6.95%483.83M
1.25%493.42M
-17.35%427.38M
-26.45%405.83M
-25.88%452.39M
-21.21%487.33M
-14.37%517.10M
-11.74%551.79M
-5.08%610.38M
45.76%618.50M
41.56%603.85M
57.70%625.17M
54.38%643.07M
10.29%424.33M
6.18%426.57M
Total liabilities
-18.32%316.94M
-20.77%327.19M
-6.49%382.51M
-8.99%379.98M
8.37%388.03M
13.36%412.97M
11.48%409.05M
13.25%417.50M
-0.73%358.06M
4.60%364.29M
7.64%366.94M
23.07%368.65M
22.51%360.70M
21.50%348.28M
737.00%340.88M
633.49%299.54M
1934.02%294.42M
1346.15%286.64M
66.19%40.73M
101.07%40.84M
Total equity
-62.53%12.75M
-47.49%37.21M
-134.87%-29.42M
-552.81%-44.73M
-28.79%34.02M
-19.56%70.87M
-29.92%84.37M
-93.35%9.88M
-75.00%47.78M
-66.39%88.10M
-56.64%120.38M
-51.22%148.45M
-42.22%191.09M
-26.46%262.10M
-27.63%277.62M
-21.11%304.31M
-13.40%330.75M
-10.16%356.43M
6.49%383.61M
1.13%385.73M
Net operating income
-142.23%-25.92M
246.98%98.00M
-171.12%-27.36M
-88.74%-40.24M
71.28%-10.70M
-94.10%-66.67M
72.34%-10.09M
16.08%-21.32M
-51.63%-37.25M
-221.47%-34.35M
-105.52%-36.47M
-5.23%-25.41M
-16.91%-24.57M
57.77%-10.69M
-153.31%-17.75M
-351.77%-24.15M
9.44%-21.01M
-167.33%-25.30M
58.82%-7.01M
148.91%9.59M
Net investment
135.62%34.98M
350.03%73.50M
76.19%103.28M
1590.70%36.40M
-78.36%14.85M
-159.77%-29.40M
91.35%58.62M
88.06%-2.44M
-19.65%68.62M
128.77%49.18M
194.45%30.64M
71.19%-20.45M
127.29%85.40M
132.23%21.50M
-399.23%-32.43M
-287.02%-71.00M
-651.59%-312.91M
-1953.64%-66.69M
129.06%10.84M
-49.65%37.96M
Net financing
104.23%1.21M
-256.47%-43.13M
-114.59%-10.39M
-220.55%-50.50M
-109.71%-28.59M
634.35%27.57M
2418.68%71.23M
410.48%41.89M
63.72%-13.63M
-364.70%-5.16M
-108.30%-3.07M
-3223.15%-13.49M
-915.23%-37.57M
-99.22%1.95M
15263.90%37.03M
-22.02%432.00K
2659.88%4.61M
199373.02%251.34M
-8.37%241.00K
680.28%554.00K

FAQs

What is the total revenue of AnaptysBio Inc?

According to AnaptysBio Inc's FY2025 earnings report, its total revenue reached 234.60M, with a year-on-year change of 91.28M.

What are the current assets of AnaptysBio Inc?

According to AnaptysBio Inc's FY2025 earnings report, its current assets were 350.25M, with a year-on-year change of -18.90.

What are the total assets of AnaptysBio Inc?

According to AnaptysBio Inc's FY2025 earnings report, its total assets of AnaptysBio Inc were 364.39M, with a year-on-year change of -24.69.

What are the total liabilities of AnaptysBio Inc?

According to AnaptysBio Inc's FY2025 earnings report, its total liabilities of AnaptysBio Inc were 327.19M, with a year-on-year change of -20.77.

What is the total equity of AnaptysBio Inc?

According to AnaptysBio Inc's FY2025 earnings report, its total equity of AnaptysBio Inc was 37.21M, with a year-on-year change of -47.49.

What is the net operating income of AnaptysBio Inc?

According to AnaptysBio Inc's FY2025 earnings report, its net operating income of AnaptysBio Inc was 47.90M, with a year-on-year change of 141.67.

What is the net investment of AnaptysBio Inc?

According to AnaptysBio Inc's FY2025 earnings report, its net investment of AnaptysBio Inc was 228.03M, with a year-on-year change of 139.03.

What is the net financing of AnaptysBio Inc?

According to AnaptysBio Inc's FY2025 earnings report, its net financing of AnaptysBio Inc was -132.61M, with a year-on-year change of -204.38.

What is the Earnings Per Share (EPS) of AnaptysBio Inc?

According to AnaptysBio Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.46, with a year-on-year change of 91.01.

What is the net income of AnaptysBio Inc?

According to AnaptysBio Inc's FY2025 earnings report, its net income was -13.23M, with a year-on-year change of 90.89.

What is the net margin of AnaptysBio Inc?

According to AnaptysBio Inc's FY2025 earnings report, its net profit margin was -5.64, with a year-on-year change of 96.46.

What is the debt-to-asset ratio of AnaptysBio Inc?

According to AnaptysBio Inc's FY2025 earnings report, its debt-to-asset ratio was 75.89, with a year-on-year change of 3.89.

What is the Return on Equity (ROE) of AnaptysBio Inc?

According to AnaptysBio Inc's FY2025 earnings report, its Return on Equity (ROE) was -24.49, with a year-on-year change of 86.60.

What is the Return on Assets (ROA) of AnaptysBio Inc?

According to AnaptysBio Inc's FY2025 earnings report, its Return on Assets (ROA) was -3.12, with a year-on-year change of 89.94.

What is the operating profit of AnaptysBio Inc?

According to AnaptysBio Inc's FY2025 earnings report, its operating profit was 47.90M, with a year-on-year change of 141.67.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.